Address & contact
https://www.demerx.com/demerx-nb-inc-advances-study-for-alcohol-use-disorder-treatment/Specialties
Reports that name this provider
- Ibogaine Treatment Legality in United States
- FDA-cleared Phase I clinical trial of noribogaine hydrochloride (DMX-1001) for alcohol use disorder; dose-ranging 20-80 mg daily with no clinically relevant cardiac findings